$-0.03
(Market cap
$49 Mln
Recently Viewed
Clear AllMarket cap
$49 Mln
Revenue (TTM)
$247 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-1 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
3.5
Debt to Equity
0
Book Value
$4.1
EPS
$-0.3
Face value
--
Shares outstanding
21,400,495
CFO
$321.54 Mln
EBITDA
$339.34 Mln
Net Profit
$223.55 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
PetMed Express (PETS)
| -30.5 | -0.2 | -32.2 | -36.1 | -47.5 | -40.9 | -19.0 |
|
BSE Sensex
| -8.5 | 5.3 | -5.9 | -3.4 | 8.2 | 9.3 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
PetMed Express (PETS)
| -33.6 | -36.0 | -57.3 | -29.9 | -21.2 | 36.3 | 1.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
PetMed Express (PETS)
|
2.2 | 49.0 | 227.0 | -6.3 | 0.3 | 0.4 | -- | 1.5 |
| 1.4 | 23.4 | 7.1 | -46.8 | -362.5 | -377.7 | -- | 2.6 | |
| 34.7 | 19,338.2 | 15,649.1 | 1,081.2 | 9.3 | 42.5 | 18.1 | 8.0 | |
| 371.1 | 1,427.7 | 85.0 | 41.0 | 49.2 | -- | 36 | 58.7 |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers... non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida. Read more
CEO, President & Director
Mr. Mathew N. Hulett
CEO, President & Director
Mr. Mathew N. Hulett
Headquarters
Delray Beach, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of PetMed Express Inc (PETS) is $2.23 (NASDAQ) as of 29-Apr-2026 12:12 EDT. PetMed Express Inc (PETS) has given a return of -47.49% in the last 3 years.
Since, TTM earnings of PetMed Express Inc (PETS) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
-7.64
|
0.56
|
|
2024
|
-13.12
|
1.01
|
|
2023
|
64.23
|
3.00
|
|
2022
|
24.86
|
3.69
|
|
2021
|
29.67
|
5.02
|
The 52-week high and low of PetMed Express Inc (PETS) are Rs 4.32 and Rs 1.57 as of 29-Apr-2026.
PetMed Express Inc (PETS) has a market capitalisation of $ 49 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in PetMed Express Inc (PETS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.